- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- McKesson (NYSE: MCK) hit a new 52-week high Wednesday as it is currently trading at $117.08, above its previous 52-week high of $116.94 with 532,675 shares traded as of 12:45 p.m. ET. Average volume has been 1.4 million shares over the past 30 days. McKesson has a market cap of $25.97 billion and is part of the services sector and wholesale industry. Shares are up 18.7% year to date as of the close of trading on Tuesday. McKesson Corporation, together with its subsidiaries, delivers pharmaceuticals, medical supplies, and health care information technologies to the healthcare industry primarily in the United States. It operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The company has a P/E ratio of 20.5, above the S&P 500 P/E ratio of 17.7.